Skip to main content
. 2024 Mar 5;22:242. doi: 10.1186/s12967-024-04920-6

Fig. 1.

Fig. 1

Study design. ICI immune checkpoint inhibitor, CT chemotherapy, AIFA Italian Medicines Agency, TA tumor assessment, PD progression disease, C therapy cycle, CTAD sodium citrate, theophylline, adenosine and dipyridamole, EDTA ethylenediamine tetraacetic acid. Created with BioRender.com